{
    "2021-03-01": [
        [
            {
                "time": "2023-03-05",
                "original_text": "药明康德：约3.48万股限制性A股股票已解除限售并于3月5日上市",
                "features": {
                    "keywords": [
                        "药明康德",
                        "限售股",
                        "解除限售",
                        "上市"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-05",
                "original_text": "北向资金今日净流入近37亿元，净卖出药明康德5.54亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "净卖出",
                        "药明康德"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-05",
                "original_text": "医药行业一周观察：龙头延续回调趋势 关注二线投资机会",
                "features": {
                    "keywords": [
                        "医药行业",
                        "回调趋势",
                        "二线投资机会"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-05",
                "original_text": "东吴证券 - 医药生物行业：新冠疫苗逐步获批，巨大期权有望加速兑现",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "医药生物",
                        "新冠疫苗",
                        "获批",
                        "期权兑现"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-05",
                "original_text": "[异动股] 药明康德(02359-HK)涨7.61%",
                "features": {
                    "keywords": [
                        "异动股",
                        "药明康德",
                        "涨7.61%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}